Press Release

  View printer-friendly version

« Back

West Pharmaceutical Services, Inc. Clarifies Statements Regarding Debiotech, S.A. and Debiopharm, S.A

LIONVILLE, Pa., July 24 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today clarified references to Debiotech, S.A. and Debiopharm, S.A. that were contained in recent company press releases. In a release issued July 17, 2001, West Pharmaceutical Services referred to Debiotech, S.A. as a subsidiary of The Debio Group. In fact, Debiotech, S.A. is an independent company, and not a subsidiary of The Debio Group. In a release issued on July 19, 2001, West Pharmaceutical Services stated that it has licensed a single- use, reconstitution system from Debiopharm, S.A. The license is with Debiotech, S.A.

About West Pharmaceutical Services

West Pharmaceutical Services supports global pharmaceutical and healthcare markets with products and services that enhance the effectiveness of drug delivery and product dispensing. West Pharmaceutical Services' technologies include drug formulation research and development, clinical research and laboratory services and the design, development and manufacture of components and systems for dispensing and delivering pharmaceutical, healthcare and consumer products. For more information, visit West Pharmaceutical Services at www.westdrugdelivery.com and www.westpharma.com.

Statements concerning forecasted results, financial or otherwise, which are contained in the above material, constitute "forward looking statements" that involve risks and uncertainties. The Company's actual results may differ materially from those expressed in any forward looking statement and are dependent on a number of factors including, but not limited to, sales demand, timing of customers' projects, competitive pressures, the strength or weakness of the U.S. dollar, inflation, the cost of raw materials, successful continuance of cost-improvement programs and statutory tax rates.

Contact:
     West Pharmaceutical Services        Morgen-Walke Associates
     William F. O'Dell                   Theresa Vogt
     Vice President,                     212-850-5631
     Global Marketing                    tvogt@morgenwalke.com

610-594-3365
Bill_O'Dell@westpharma.com

Schwartz Communications

Shoba Vaitheeswaran

781-684-0770

westpharma@schwartz-pr.com

                     MAKE YOUR OPINION COUNT - Click Here
               http://tbutton.prnewswire.com/prn/11690X44037361

SOURCE West Pharmaceutical Services, Inc.

CONTACT: William F. O'Dell, Vice President, Global Marketing of West Pharmaceutical Services, 610-594-3365, or Bill_O'Dell@westpharma.com; or Theresa Vogt of Morgen-Walke Associates, 212-850-5631, or tvogt@morgenwalke.com; or Shoba Vaitheeswaran of Schwartz Communications, 781-684-0770, or westpharma@schwartz-pr.com/